Aryl Hydrocarbon Receptor (AHR) is a Novel Druggable Pathway Controlling Malignant Progenitor Proliferation in Chronic Myeloid Leukemia (CML)Melanie Gentil,Patricia Hugues,Christophe Desterke,Gladys Telliam,Ivan Sloma,Lucas E. B. Souza,Seda Baykal,Jerome Artus,Frank Griscelli,Agnes Guerci,Hyacinthe Johnson-Ansah,Adlen Foudi,Annelise Bennaceur-Griscelli,Ali G. TurhanPloS one(2018)引用 15|浏览43暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要